Eli Lilly launched Mounjaro, a weight-loss injectable, in India, priced at ₹4,375 for 5 mg, targeting obesity and type-2 diabetes management.

Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes ...

Mounjaro is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

With the growing demand for weight-loss solutions, many individuals in India have resorted to purchasing obesity drugs from ...

Mounjaro is approved as an adjunct to a reduced-calorie diet and increased physical activity for adults with an initial body ...

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...

When consumed in moderation, beer may offer several health advantages, particularly for the heart, digestive system & even ...

Childhood obesity is a pandemic that continues to threaten the health of children in the UK, despite several calls for action over the years.

Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard ...

Heavy alcohol use is taking an earlier toll, landing more young Americans onto transplant lists. The obesity epidemic makes ...